UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010579
Receipt No. R000012338
Scientific Title Phase 2 study of neoadjuvant tri-weekly Nab-paclitaxel and Trastuzumab followed by FEC(5-FU/epirubicin/cyclophosphamide) in patients for HER2 positive breast cancer.
Date of disclosure of the study information 2013/04/30
Last modified on 2013/04/21 13:18:36

No. Disposal Last modified on Item of update
1 Insert 2013/04/24 00:04:09


Contact us.